the SPM podcast podcast

Episode 17 Dr. Trond Hansen "Synthesizing Resolution: Protectins, Stereochemistry & the Chemistry of SPMs"

0:00
1:04:37
Manda indietro di 15 secondi
Manda avanti di 15 secondi

"Synthesizing Resolution:Protectins, Stereochemistry & the Chemistry of SPMs" with Professor Trond Vidar Hansen, Professor of Pharmaceutical Chemistry at the University of Oslo,

for a deep dive into the synthetic chemistry that underpins specialized pro-resolving mediator (SPM) research.

Professor Hansen is a leading figure at the intersection of organic synthesis and lipid mediator biology. His laboratory specializes in the stereoselective total synthesis of SPMs — particularly the protectin family and n-3 docosapentaenoic acid (n-3 DPA)-derived resolvins, protectins, and maresins — as well as the design of metabolically more stable analogs such as 3-oxa-PD1n-3 DPA.

Through close collaborations with Charles Serhan and other pioneers in the field, his group has provided authentic, stereochemically pure SPMs that have enabled critical biological and translational studies in inflammation resolution, pain, itch, and tissue protection.

In this conversation we explore:

How an early interest in chemistry and work on insect-derived oxygenated polyunsaturated fatty acids led him into the world of SPMs

The critical importance of stereochemistry and why total synthesis has been essential for confirming SPM structures

The unique chemistry and biology of protectins and n-3 DPA-derived mediators

Why protectins/neuroprotectins appear especially relevant in immunoprivileged tissues such as the brain and eyes

The challenges of synthesizing highly unsaturated, chemically sensitive lipid mediators (conjugated trienes and tetraenes)

Design and biological evaluation of the more stable 3-oxa-PD1n-3 DPA analog in pain and itch models

Autacoid properties of SPMs — local, on-demand action and the difficulty of measuring them in plasma

Why these mediators work at nanomolar and even picomolar concentrations

The concept of resolution pharmacology and the translational potential of SPM analogs versus omega-3 precursors

Reflections on collaborations with chemists such as Nicos Petasis, Bernd Spur, and Charles Serhan

Whether you are a chemist, biologist, clinician, or simply fascinated by how the body actively resolves inflammation, this episode offers a rare look at the synthetic work that makes modern SPM research possible.

Papers mentioned:

Total Synthesis of the Lipid Mediator PD1n-3 DPA (2014)

https://pubs.acs.org/doi/10.1021/np4009865

Total Synthesis of MaR1n-3 DPA Utilizing an sp³–sp³ Negishi Cross-Coupling (2014)

https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/chem.201404721

Free full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC4232850/

The Protectin Family of Specialized Pro-resolving Mediators (2019 review)

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01582/full

A new synthetic protectin D1 analog 3-oxa-PD1n-3 DPA reduces neuropathic pain and chronic itch (2021)

https://pubs.rsc.org/en/content/articlelanding/2021/ob/d0ob02136a

Biology and Total Synthesis of n-3 Docosapentaenoic Acid-Derived Specialized Pro-Resolving Mediators (2024 review)

https://www.mdpi.com/1420-3049/29/12/2833

Altri episodi di "the SPM podcast"